SCHEMBL9495675

SCHEMBL9495675

COc1cccc(C2(OC(=O)C(=O)O)CN3CCC2CC3)c1

nearest known ligand 0.46

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.46
SLC6A4 P31645 2/20 0.46
SLC6A2 P23975 1/20 0.45
SLC6A3 Q01959 1/20 0.45
MEN1 O00255 2/20 0.40
KMT2A Q03164 2/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
OPRM1 P35372 1/20 0.40
OPRD1 P41143 1/20 0.40
OPRK1 P41145 1/20 0.40
OPRL1 P41146 1/20 0.40
MAPT P10636 1/20 0.39
MMP13 P45452 1/20 0.39
GRIN2B Q13224 2/20 0.39
BACE1 P56817 2/20 0.39
ADAM17 P78536 1/20 0.39
CTSD P07339 1/20 0.39
CTSE P14091 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9492487 0.94 SLC6A4 (0.46) ALDH1A1SLC6A4SLC6A2SLC6A3MEN1
SCHEMBL9493463 0.89 SLC6A4 (0.50) ALDH1A1SLC6A4SLC6A2SLC6A3MEN1
SCHEMBL9494634 0.82 SLC6A2 (0.43) ALDH1A1SLC6A4SLC6A2SLC6A3MEN1
Oxalic Acid SCHEMBL9495666 0.81 CHRM1 (0.50) ALDH1A1SLC6A4SLC6A2SLC6A3MEN1
SCHEMBL9493425 0.81 CHRM3 (0.45) KMT2AOPRM1OPRD1OPRK1OPRL1
SCHEMBL9492737 0.81 CHRM2 (0.42) ALDH1A1MEN1KMT2AMMP13
SCHEMBL9492441 0.81 CHRM2 (0.44) ALDH1A1MEN1KMT2AMMP13
Oxalic Acid SCHEMBL9492481 0.77 ALDH1A1 (0.48) ALDH1A1SLC6A4SLC6A2SLC6A3MEN1
SCHEMBL9492494 0.76 CHRM1 (0.56) ALDH1A1SLC6A4SLC6A2SLC6A3MEN1
SCHEMBL9496244 0.76 CHRM2 (0.50) ALDH1A1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5177084-A 1-Azabicycles, Treating Mental Disorders MERCK SHARP & DOHME LTD. (GB) 1993-01-05 US disclosed
EP-0412797-A2 The therapeutic use of substituted benzenes, formulations thereof and novel substituted benzenes MERCK SHARP & DOHME LTD. (GB) 1991-02-13 EP disclosed